| Adenosine receptors: expression, function and regulation S Sheth, R Brito, D Mukherjea, LP Rybak, V Ramkumar International journal of molecular sciences 15 (2), 2024-2052, 2014 | 491 | 2014 |
| Mechanisms of cisplatin-induced ototoxicity and otoprotection S Sheth, D Mukherjea, LP Rybak, V Ramkumar Frontiers in cellular neuroscience 11, 2017 | 373 | 2017 |
| Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway S Sheth, S Jajoo, T Kaur, D Mukherjea, K Sheehan, LP Rybak, ... PloS one 7 (12), e51655, 2012 | 272 | 2012 |
| TRPV1: a potential drug target for treating various diseases R Brito, S Sheth, D Mukherjea, LP Rybak, V Ramkumar Cells 3 (2), 517-545, 2014 | 179 | 2014 |
| Adenosine A1 receptor protects against cisplatin ototoxicity by suppressing the NOX3/STAT1 inflammatory pathway in the cochlea T Kaur, V Borse, S Sheth, K Sheehan, S Ghosh, S Tupal, S Jajoo, ... Journal of Neuroscience 36 (14), 3962-3977, 2016 | 106 | 2016 |
| Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity V Borse, RFH Al Aameri, K Sheehan, S Sheth, T Kaur, D Mukherjea, ... Cell death & disease 8 (7), e2921-e2921, 2017 | 99 | 2017 |
| NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss D Mukherjea, S Jajoo, K Sheehan, T Kaur, S Sheth, J Bunch, C Perro, ... Antioxidants & redox signaling 14 (6), 999-1010, 2011 | 99 | 2011 |
| The design and screening of drugs to prevent acquired sensorineural hearing loss D Mukherjea, LP Rybak, KE Sheehan, T Kaur, V Ramkumar, S Jajoo, ... Expert opinion on drug discovery 6 (5), 491-505, 2011 | 77 | 2011 |
| Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer S Jajoo, D Mukherjea, T Kaur, KE Sheehan, S Sheth, V Borse, LP Rybak, ... Antioxidants & redox signaling 19 (16), 1863-1876, 2013 | 65 | 2013 |
| Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol RFH Al Aameri, S Sheth, EMA Alanisi, V Borse, D Mukherjea, LP Rybak, ... PLoS One 12 (5), e0177198, 2017 | 54 | 2017 |
| Targeting inflammatory processes mediated by TRPVI and TNF-α for treating noise-induced hearing loss A Dhukhwa, P Bhatta, S Sheth, K Korrapati, C Tieu, C Mamillapalli, ... Frontiers in Cellular Neuroscience 13, 444, 2019 | 50 | 2019 |
| The endocannabinoid/cannabinoid receptor 2 system protects against cisplatin-induced hearing loss S Ghosh, S Sheth, K Sheehan, D Mukherjea, A Dhukhwa, V Borse, ... Frontiers in cellular neuroscience 12, 271, 2018 | 47 | 2018 |
| Early investigational drugs for hearing loss D Mukherjea, S Ghosh, P Bhatta, S Sheth, S Tupal, V Borse, T Brozoski, ... Expert opinion on investigational drugs 24 (2), 201-217, 2015 | 47 | 2015 |
| Capsaicin protects against cisplatin ototoxicity by changing the STAT3/STAT1 ratio and activating cannabinoid (CB2) receptors in the cochlea P Bhatta, A Dhukhwa, K Sheehan, RFH Al Aameri, V Borse, S Ghosh, ... Scientific reports 9 (1), 4131, 2019 | 42 | 2019 |
| Progress in drug delivery and diagnostic applications of carbon dots: a systematic review H Kaurav, D Verma, A Bansal, DN Kapoor, S Sheth Frontiers in Chemistry 11, 1227843, 2023 | 40 | 2023 |
| Role of β-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery S Jajoo, D Mukherjea, S Kumar, S Sheth, T Kaur, LP Rybak, V Ramkumar American Journal of Physiology-Cell Physiology 298 (1), C56-C65, 2010 | 38 | 2010 |
| Oral administration of caffeine exacerbates cisplatin-induced hearing loss S Sheth, K Sheehan, A Dhukhwa, RFH Al Aameri, C Mamillapalli, ... Scientific reports 9 (1), 9571, 2019 | 18 | 2019 |
| Transient receptor potential channels and auditory functions V Ramkumar, S Sheth, A Dhukhwa, R Al Aameri, L Rybak, D Mukherjea Antioxidants & Redox Signaling 36 (16-18), 1158-1170, 2022 | 16 | 2022 |
| Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss A Dhukhwa, RFH Al Aameri, S Sheth, D Mukherjea, L Rybak, ... Scientific Reports 11 (1), 8116, 2021 | 11 | 2021 |
| Trans-tympanic drug delivery for the treatment of ototoxicity K Sheehan, S Sheth, D Mukherjea, LP Rybak, V Ramkumar Journal of visualized experiments: JoVE, 56564, 2018 | 11 | 2018 |
